HRS-9190

HRS-9190 is an investigational small molecule drug developed for use as a skeletal muscle relaxant during surgical procedures. It is being studied as an intraoperative medication, specifically for facilitating tracheal intubation during the induction period of general anesthesia and for maintaining skeletal muscle relaxation throughout surgery. The drug is administered intravenously and is classified as a Class 1 new drug in China, indicating it represents a novel chemical entity not previously approved domestically or internationally. As of mid-2025, its precise mechanism of action has not been publicly disclosed[1][2][4][5][7].